Jolanta Gozdzik

Jolanta Gozdzik

Auto-generated profile, based on publicly available information

Jolanta Gozdzik

Department of Medical Education, Jagiellonian University Medical College, Kraków, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
BWBeata Wolska-Kusnierz
Beata Wolska-Kusnierz
APAgata Pastorczak
Agata Pastorczak
WFWojciech Fendler
Wojciech Fendler
AWAnna Wakulinska
Anna Wakulinska
BDBozena Dembowska-Baginska
Bozena Dembowska-Baginska
WMWojciech Młynarski
Wojciech Młynarski
Purpose: Nijmegen breakage syndrome (NBS) is a DNA repair disorder with a high predisposition to hematologic malignancies. Experimental Design: We describe the natural history of NBS, including cancer incidence, risk of death, and the potential effectiveness of hematopoietic stem cell transplantation (HSCT) in preventing both pathologies: malignancy and immunodeficiency. Results: Among 241 patients with NBS enrolled in the study from 11 countries, 151 (63.0%) patients were diagnosed with cancer. Incidence rates for primary and secondary cancer, tumor characteristics, and risk factors affecting overall survival (OS) were estimated. The cumulative cancer incidence was 40.21% ± 3.5% and 77.78% ± 3.4% at 10 years and 20 years of follow-up, respectively. Most of the tumors n = 95 (62.9%) were non-Hodgkin lymphomas. Overall, 20 (13.2%) secondary malignancies occurred at a median age of 18 (interquartile range, 13.7–21.5) years. The probability of 20-year overall survival (OS) for the whole cohort was 44.6% ± 4.5%. Patients who developed cancer had a shorter 20-year OS than those without malignancy (29.6% vs. 86.2%; P < 10−5). A total of 49 patients with NBS underwent HSCT, including 14 patients transplanted before malignancy. Patients with NBS with diagnosed cancer who received HSCT had higher 20-year OS than those who did not (42.7% vs. 30.3%; P = 0.038, respectively). In the group of patients who underwent preemptive transplantation, only 1 patient developed cancer, which is 6.7 times lower as compared with nontransplanted patients [incidence rate ratio 0.149 (95% confidence interval, 0.138–0.162); P < 0.0001]. Conclusions: There is a beneficial effect of HSCT on the long-term survival of patients with NBS transplanted in their first complete remission of cancer.

21 May 2012 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
KDKatarzyna Drabko
Katarzyna Drabko
ARAnna Raciborska
Anna Raciborska
KBK Bilska
K Bilska
JSJan Styczyński
Jan Styczyński
Marek UssowiczMarek Ussowicz
Marek Ussowicz
JKJerzy Roman Kowalczyk
Jerzy Roman Kowalczyk

13 October 2014 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
JGJ Gozdzik
J Gozdzik
KRK Rewucka
K Rewucka
AKAleksandra Krasowska-Kwiecień
Aleksandra Krasowska-Kwiecień
APA Pieczonka
A Pieczonka
RDR Debski
R Debski
JWJ Wachowiak
J Wachowiak

16 November 2004 in Blood
Verified
Journal Article
Open access
MKMagda Kucia
Magda Kucia
RRRyan Reca
Ryan Reca
Marcin WysoczynskiMarcin Wysoczynski
Marcin Wysoczynski
JGJolanta Gozdzik
Jolanta Gozdzik
JRJanina Ratajczak
Janina Ratajczak
MRMariusz Ratajczak
Mariusz Ratajczak
During mobilization hematopoietic stem cells (HSC) egress from the bone marrow (BM) into peripheral blood (PB) where they temporarily circulate and can be collected by leukapheresis. However, recently we demonstrated that BM, in addition to HSC, contains heterogeneous populations of CXCR4+ tissue-committed stem cells (TCSC) and we contend that the contribution of these cells to organ/tissue regeneration after transplantation of BM cells has been misinterpreted as evidence for “plasticity” or “trans-dedifferentiation” of HSC (

31 March 2023
Verified
Other
Open access
BWBeata Wolska-Kusnierz
Beata Wolska-Kusnierz
APAgata Pastorczak
Agata Pastorczak
WFWojciech Fendler
Wojciech Fendler
AWAnna Wakulinska
Anna Wakulinska
BDBozena Dembowska-Baginska
Bozena Dembowska-Baginska
WMWojciech Mlynarski
Wojciech Mlynarski
The dynamics of primary cancer incidence among patients with NBS described using the three-stage joint-point model.

31 March 2023
Verified
Other
Open access
BWBeata Wolska-Kusnierz
Beata Wolska-Kusnierz
APAgata Pastorczak
Agata Pastorczak
WFWojciech Fendler
Wojciech Fendler
AWAnna Wakulinska
Anna Wakulinska
BDBozena Dembowska-Baginska
Bozena Dembowska-Baginska
WMWojciech Mlynarski
Wojciech Mlynarski